CAJ | 학술논문

目的系统评价和分析17国国家药物政策的主要内容,为建立适合我国国情的国家药物政策提供决策依据.方法共检索13个电子数据库、WHO、世界银行和17国药品管理相关网站.用预先设计的数据提取表收集相关信息,根据设计的理论框架对提取的信息进行分析和描述.结果共纳入17个国家的182篇文献,各国药物政策共同关注的要点是:药品规制和质量保障、合理用药、药品供应、基本药物遴选、人力资源开发与培训、传统医药、药品筹资和可支付能力、药品研究、药物政策的监测和评估、技术合作和本国医药产业发展.我国在药物遴选、质量保障、供应、定价及传统医药等方面开展工作,而对药品研究、政策监测、本国医药发展和技术合作方面还有待进一步加强.结论建议筹备相关组织机构和规范工作程序,推动国家基本药物政策相关立法工作,健全基本药物目录的遴选机制和配套实施政策,整顿药品生产流通秩序,建立科学合理的药品定价机制和基本药物可及性评估体系,加强药物政策的监测与评估,适时更新和完善国家药物政策.
목적 계통평개화분석17국국가약물정책적주요내용,위건립괄합아국국정적국가약물정책제공결책의거.방법 공검색13개전자수거고、WHO、세계은행화17국약품관리상관망참.용예선설계적수거제취표수집상관신식,근거설계적이론광가대제취적신식진행분석화묘술.결과 공납입17개국가적182편문헌,각국약물정책공동관주적요점시:약품규제화질량보장、합리용약、약품공응、기본약물린선、인력자원개발여배훈、전통의약、약품주자화가지부능력、약품연구、약물정책적감측화평고、기술합작화본국의약산업발전.아국재약물린선、질량보장、공응、정개급전통의약등방면개전공작,이대약품연구、정책감측、본국의약발전화기술합작방면환유대진일보가강.결론 건의주비상관조직궤구화규범공작정서,추동국가기본약물정책상관입법공작,건전기본약물목록적린선궤제화배투실시정책,정돈약품생산류통질서,건립과학합리적약품정개궤제화기본약물가급성평고체계,가강약물정책적감측여평고,괄시경신화완선국가약물정책.
Objectives To analyze the development and implementation of the national drug policy in order to provide decision-making for the establishment of the Chinese national drug policy. Methods Nineteen electronic databases, the WHO, the World Bank, and governmental websites were included in this study. A pre-designed data extraction form was used to collect information. The data were analyzed and described by a pre-designed analytic framework+ Result A total of 182 studies were included in this review. The main points of common concern in the national drug policy were: drug regulation and quality assurance, rational use of drugs, drug supply, the selection of essential drugs, human resource development and training, traditional medicine, drug financing and affordability, drug research, monitoring and assessment of the nation drug policy, technical cooperation, and the national pharmaceutical industry. The selection of essential drugs, quality assurance, supply, pricing, and supply of traditional medicine weregradually carried out in China. Pharmaceutical research, monitoring and evaluation, as well as the development of pharmaceutical industry and technical cooperation within it should be further strengthened. Conclusion China should establish related organizations and working procedures; speed up the implementation of the legislation of national drug policy; integrate the mechanism of essential drugs selection and supply system; regulate the order of medicine production and regulation; establish scientific and reasonable pricing mechanisms for drugs and assessment systems; strengthen themonitoring and evaluation of national drug policy and update and improve the national drug policy.